3
Simple protocol for the potential anti-cancer drugs synthesis

Simple protocol for the potential anti-cancer drugs synthesis

Chemists from Russia and the USA have created a protocol for the synthesis of potential anti-cancer drugs. It allows obtaining promising compounds “in one pot” — that is, by mixing all the reagents in a single reaction.

Derivatives of organic substances quinolines are used in pharmaceuticals to develop potential antihypertensive, anticonvulsant and anti-inflammatory drugs. Their biological activity can be enhanced by adding cyclic fragments to their structure. For example, the complex of the cyclic compound oxadiazole and a quinoline derivative has potential anticancer activity. To obtain other similar compounds and test their activity, it is necessary to find an effective way to synthesize them. Such a protocol was proposed by a team of chemists from the North Caucasus Federal University, RUDN University and the University of Kansas (USA) under the guidance of Doctor Alexander Aksenov.

“Recently, we described the preparation of novel antitumor agents with in vitro differentiation activity against neuroblastoma cancer cell lines. we had a task of building a focused library of perspective ‘chimeric’ antitumor drug candidates possessing both triazoloquinoline and oxadiazole rings. An expeditious and concise synthetic method was needed to allow for a highly efficient installation of both heterocyclic cores in a single-pot fashion”, said Elena Sorokina, PhD, associate research professor at the Department of Organic Chemistry of the RUDN University.

The key to the synthesis of compounds with different cyclic components were nitroalkanes — the derivatives of alkanes with added nitrogen complex. They act like electrophiles meaning that they can accept an electron pair and form a chemical bond. This gives the opportunityy for a “one pot” type reaction, when all the reagents are mixed in a single reaction vessel and come together without additional intervention.

Chemists have tested this synthesis approach experimentally. Scientists have selected optimal conditions — temperature, reagents and a medium. As a result, at a temperature of 130℃ in polyphosphoric acid, 90% of the reaction efficiency was achieved (the experimental yield of the product was 90% of the calculated theoretically). To test the universality of the method, chemists obtained more than 10 compounds with a yield of 55%-90% according to this principle. Scientists have suggested that this method can also be used for the synthesis of more complex substances, in which even more cyclic fragments are combined.

“The method provides an expeditious and direct access to triazoloquinolines bearing an oxadiazole substituent, which might be of interest for medicinal chemistry. Furthermore, this research paves the road for development of other acid-mediated cascade transformations for preparation of complex heterocyclic compounds. In principle, the same strategy can potentially be employed for stepwise assembly of longer linear oligomeric chains with repeating oxadiazole units, provided that greater annulation efficiency could be achieved at every step. Synthesis of a focused library for biological studies is currently underway in our laboratories”, said Elena Sorokina, PhD, associate research professor at the Department of Organic Chemistry of the RUDN University.

The results are published in Molecules.

International Projects View all
Visiting Professors View all
12 Dec 2024
In 2024, RUDN started accepting applications for the new annual Prize for Scientific Achievement in Chemistry. The award was established to honour contributions to fundamental and applied research, as well as merit in achieving the UN Sustainable Development Goals.
187
Similar newsletter View all
20 Apr
A volunteer of the Red Army and head of the veterinary medicine course — Matilda Mityaeva's combat and scientific path

Matilda Pavlovna Mityaeva was born in 1925. In November 1942, she volunteered for frontline duty. She participated in the Great Patriotic War from November 1942 to June 1945 as part of the 53rd Infantry Division of the 475th Infantry Regiment. She was wounded twice.

24
20 Apr
RUDN University Team – the 1st place in the all-russian competitive selection of scientific projects “Technologies for human health”

The team led by Sergey Zyryanov, Head of the Department of General and Clinical Pharmacology, became the winner of the All-Russian competition of scientific projects "Technologies for Human Health".

32
20 Apr
RUDN University Scientific Agenda to 2030: New Programme for R&D and Innovation Activities Development

RUDN University constantly adapts to the changes of the modern world and responds to challenges flexibly. This allows us to keep the standard of a world-class research university. The sphere of science is no exception. Peter Dokukin, Head of the Research Division, presented the updated R&D Programme at the meeting of the RUDN University Academic Council.

23
Similar newsletter View all